FTI250117C25000
- 7.27
- +1.25+20.76%
TechnipFMC Newsroom
Piper Sandler Initiates TechnipFMC(FTI.US) With Buy Rating, Announces Target Price $39
Barclays Maintains TechnipFMC(FTI.US) With Buy Rating, Raises Target Price to $42
TechnipFMC Is Maintained at Overweight by Barclays
TechnipFMC Price Target Raised to $42.00/Share From $37.00 by Barclays
BMO Capital Initiates TechnipFMC(FTI.US) With Hold Rating, Announces Target Price $35
TechnipFMC Price Target Announced at $38.00/Share by Goldman Sachs
TechnipFMC Analyst Ratings
Goldman Sachs Initiates TechnipFMC(FTI.US) With Buy Rating, Announces Target Price $38
TechnipFMC's Unique Growth Prospects and Market Leadership Drive Buy Rating
Jefferies Upgrades TechnipFMC to Buy From Hold, Adjusts Price Target to $40 From $29
Jefferies Upgrades TechnipFMC(FTI.US) to Buy Rating, Raises Target Price to $40
TechnipFMC Analyst Ratings
TD Cowen Maintains TechnipFMC(FTI.US) With Buy Rating, Maintains Target Price $37
TechnipFMC's Strong Market Position and Growth Prospects Drive Buy Rating
RBC Capital Initiates Coverage On TechnipFMC With Outperform Rating, Announces Price Target of $37
RBC Capital Initiates TechnipFMC(FTI.US) With Buy Rating, Announces Target Price $37
TechnipFMC Analyst Ratings
Citi Maintains TechnipFMC(FTI.US) With Buy Rating, Raises Target Price to $35
TechnipFMC Analyst Ratings
HSBC Initiates TechnipFMC(FTI.US) With Buy Rating, Announces Target Price $32